Periprosthetic Infection in Patients With Multiple Joint Arthroplasties.

Abstract

The number of total joint arthroplasties performed in the United States is increasing every year. Owing to the aging population and excellent long-term prosthesis survival, 45% of patients who undergo joint arthroplasty will receive two or more joint arthroplasties during their lifetimes. Periprosthetic joint infection (PJI) is among the most common complications after arthroplasty. Evaluation and treatment of PJI in patients with multiple joint arthroplasties is challenging, and no consensus exists for the optimal management. Multiple PJI can occur simultaneously, synchronous, or separated by extended time, metachronous. Patient risk factors for both scenarios have been reported and may guide evaluation and long-term management. Whether to perform joint aspiration for asymptomatic prosthesis in the presence of suspected PJI in patients with multiple joint arthroplasties is controversial. Furthermore, no consensus exists regarding whether patients who have multiple joint arthroplasties and develop PJI in a single joint should be considered for prolonged antibiotic prophylaxis to reduce the risk of future infections. Finally, the optimal treatment of synchronous joint infections whether by débridement, antibiotics and implant retention, and one-stage or two-stage revision has not been defined. This review will summarize the best information available and provide pragmatic management strategies.

• Authors: Elie Mansour, Henry D Clarke, Mark J Spangehl, Joshua S Bingham
• Journal: The Journal of the American Academy of Orthopaedic Surgeons (J Am Acad Orthop Surg) (Oct 12 2023) ISSN: 1940-5480 [Electronic] United States
• PMID: 37831949 (Publication Type: Journal Article)
• Copyright: Copyright © 2023 by the American Academy of Orthopaedic Surgeons.